Clinical trial
A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)
NCT00032643 · US Department of Veterans Affairs, U.S. Fed · Terminated
Key facts
| NCT number | NCT00032643 |
|---|---|
| Title | A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA) |
| Official title | CSP #526 - A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA) |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | DITPA |
| Enrollment | 150 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Mar 28, 2002 |
| Last update posted | Nov 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: